Global Endocrine Testing Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 03-Aug-2020
No. of pages: 133
Inquire Before Buying

Endocrine Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Endocrine Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study

- Abbott Laboratories

- AdnaGen

- Beckman Coulter/Danaher

- Biomedical Diagnostics

- BioMerieux

- Bio-Rad

- Dako

- DiaSorin

- Eiken

- Fujirebio

- Instrumentation Laboratory

- Kyowa Medex

- Matritech

- Ortho-Clinical Diagnostics

- Roche

- Siemens

- Sysmex

- Thermo Fisher

- Tosoh

- Wako

- Wallac/PE

Market segment by Type, the product can be split into

- Tandem Mass Spectrometry

- Immunoassay

Market segment by Application, split into

- Hospitals

- Commercial Laboratories

- Ambulatory Care Centres

- Other Setting

Market segment by Regions/Countries, this report covers

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

Global Endocrine Testing Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Endocrine Testing Revenue
1.4 Market by Type
1.4.1 Global Endocrine Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Tandem Mass Spectrometry
1.4.3 Immunoassay
1.5 Market by Application
1.5.1 Global Endocrine Testing Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Commercial Laboratories
1.5.4 Ambulatory Care Centres
1.5.5 Other Setting
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Endocrine Testing Market Perspective (2015-2026)
2.2 Global Endocrine Testing Growth Trends by Regions
2.2.1 Endocrine Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Endocrine Testing Historic Market Share by Regions (2015-2020)
2.2.3 Endocrine Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Endocrine Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Endocrine Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Endocrine Testing Players by Market Size
3.1.1 Global Top Endocrine Testing Players by Revenue (2015-2020)
3.1.2 Global Endocrine Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Endocrine Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Endocrine Testing Market Concentration Ratio
3.2.1 Global Endocrine Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Endocrine Testing Revenue in 2019
3.3 Endocrine Testing Key Players Head office and Area Served
3.4 Key Players Endocrine Testing Product Solution and Service
3.5 Date of Enter into Endocrine Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Endocrine Testing Historic Market Size by Type (2015-2020)
4.2 Global Endocrine Testing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Endocrine Testing Market Size by Application (2015-2020)
5.2 Global Endocrine Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Endocrine Testing Market Size (2015-2020)
6.2 Endocrine Testing Key Players in North America (2019-2020)
6.3 North America Endocrine Testing Market Size by Type (2015-2020)
6.4 North America Endocrine Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Endocrine Testing Market Size (2015-2020)
7.2 Endocrine Testing Key Players in Europe (2019-2020)
7.3 Europe Endocrine Testing Market Size by Type (2015-2020)
7.4 Europe Endocrine Testing Market Size by Application (2015-2020)
8 China
8.1 China Endocrine Testing Market Size (2015-2020)
8.2 Endocrine Testing Key Players in China (2019-2020)
8.3 China Endocrine Testing Market Size by Type (2015-2020)
8.4 China Endocrine Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Endocrine Testing Market Size (2015-2020)
9.2 Endocrine Testing Key Players in Japan (2019-2020)
9.3 Japan Endocrine Testing Market Size by Type (2015-2020)
9.4 Japan Endocrine Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Endocrine Testing Market Size (2015-2020)
10.2 Endocrine Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Endocrine Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Endocrine Testing Market Size by Application (2015-2020)
11 India
11.1 India Endocrine Testing Market Size (2015-2020)
11.2 Endocrine Testing Key Players in India (2019-2020)
11.3 India Endocrine Testing Market Size by Type (2015-2020)
11.4 India Endocrine Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Endocrine Testing Market Size (2015-2020)
12.2 Endocrine Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Endocrine Testing Market Size by Type (2015-2020)
12.4 Central & South America Endocrine Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Endocrine Testing Introduction
13.1.4 Abbott Laboratories Revenue in Endocrine Testing Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 AdnaGen
13.2.1 AdnaGen Company Details
13.2.2 AdnaGen Business Overview
13.2.3 AdnaGen Endocrine Testing Introduction
13.2.4 AdnaGen Revenue in Endocrine Testing Business (2015-2020)
13.2.5 AdnaGen Recent Development
13.3 Beckman Coulter/Danaher
13.3.1 Beckman Coulter/Danaher Company Details
13.3.2 Beckman Coulter/Danaher Business Overview
13.3.3 Beckman Coulter/Danaher Endocrine Testing Introduction
13.3.4 Beckman Coulter/Danaher Revenue in Endocrine Testing Business (2015-2020)
13.3.5 Beckman Coulter/Danaher Recent Development
13.4 Biomedical Diagnostics
13.4.1 Biomedical Diagnostics Company Details
13.4.2 Biomedical Diagnostics Business Overview
13.4.3 Biomedical Diagnostics Endocrine Testing Introduction
13.4.4 Biomedical Diagnostics Revenue in Endocrine Testing Business (2015-2020)
13.4.5 Biomedical Diagnostics Recent Development
13.5 BioMerieux
13.5.1 BioMerieux Company Details
13.5.2 BioMerieux Business Overview
13.5.3 BioMerieux Endocrine Testing Introduction
13.5.4 BioMerieux Revenue in Endocrine Testing Business (2015-2020)
13.5.5 BioMerieux Recent Development
13.6 Bio-Rad
13.6.1 Bio-Rad Company Details
13.6.2 Bio-Rad Business Overview
13.6.3 Bio-Rad Endocrine Testing Introduction
13.6.4 Bio-Rad Revenue in Endocrine Testing Business (2015-2020)
13.6.5 Bio-Rad Recent Development
13.7 Dako
13.7.1 Dako Company Details
13.7.2 Dako Business Overview
13.7.3 Dako Endocrine Testing Introduction
13.7.4 Dako Revenue in Endocrine Testing Business (2015-2020)
13.7.5 Dako Recent Development
13.8 DiaSorin
13.8.1 DiaSorin Company Details
13.8.2 DiaSorin Business Overview
13.8.3 DiaSorin Endocrine Testing Introduction
13.8.4 DiaSorin Revenue in Endocrine Testing Business (2015-2020)
13.8.5 DiaSorin Recent Development
13.9 Eiken
13.9.1 Eiken Company Details
13.9.2 Eiken Business Overview
13.9.3 Eiken Endocrine Testing Introduction
13.9.4 Eiken Revenue in Endocrine Testing Business (2015-2020)
13.9.5 Eiken Recent Development
13.10 Fujirebio
13.10.1 Fujirebio Company Details
13.10.2 Fujirebio Business Overview
13.10.3 Fujirebio Endocrine Testing Introduction
13.10.4 Fujirebio Revenue in Endocrine Testing Business (2015-2020)
13.10.5 Fujirebio Recent Development
13.11 Instrumentation Laboratory
10.11.1 Instrumentation Laboratory Company Details
10.11.2 Instrumentation Laboratory Business Overview
10.11.3 Instrumentation Laboratory Endocrine Testing Introduction
10.11.4 Instrumentation Laboratory Revenue in Endocrine Testing Business (2015-2020)
10.11.5 Instrumentation Laboratory Recent Development
13.12 Kyowa Medex
10.12.1 Kyowa Medex Company Details
10.12.2 Kyowa Medex Business Overview
10.12.3 Kyowa Medex Endocrine Testing Introduction
10.12.4 Kyowa Medex Revenue in Endocrine Testing Business (2015-2020)
10.12.5 Kyowa Medex Recent Development
13.13 Matritech
10.13.1 Matritech Company Details
10.13.2 Matritech Business Overview
10.13.3 Matritech Endocrine Testing Introduction
10.13.4 Matritech Revenue in Endocrine Testing Business (2015-2020)
10.13.5 Matritech Recent Development
13.14 Ortho-Clinical Diagnostics
10.14.1 Ortho-Clinical Diagnostics Company Details
10.14.2 Ortho-Clinical Diagnostics Business Overview
10.14.3 Ortho-Clinical Diagnostics Endocrine Testing Introduction
10.14.4 Ortho-Clinical Diagnostics Revenue in Endocrine Testing Business (2015-2020)
10.14.5 Ortho-Clinical Diagnostics Recent Development
13.15 Roche
10.15.1 Roche Company Details
10.15.2 Roche Business Overview
10.15.3 Roche Endocrine Testing Introduction
10.15.4 Roche Revenue in Endocrine Testing Business (2015-2020)
10.15.5 Roche Recent Development
13.16 Siemens
10.16.1 Siemens Company Details
10.16.2 Siemens Business Overview
10.16.3 Siemens Endocrine Testing Introduction
10.16.4 Siemens Revenue in Endocrine Testing Business (2015-2020)
10.16.5 Siemens Recent Development
13.17 Sysmex
10.17.1 Sysmex Company Details
10.17.2 Sysmex Business Overview
10.17.3 Sysmex Endocrine Testing Introduction
10.17.4 Sysmex Revenue in Endocrine Testing Business (2015-2020)
10.17.5 Sysmex Recent Development
13.18 Thermo Fisher
10.18.1 Thermo Fisher Company Details
10.18.2 Thermo Fisher Business Overview
10.18.3 Thermo Fisher Endocrine Testing Introduction
10.18.4 Thermo Fisher Revenue in Endocrine Testing Business (2015-2020)
10.18.5 Thermo Fisher Recent Development
13.19 Tosoh
10.19.1 Tosoh Company Details
10.19.2 Tosoh Business Overview
10.19.3 Tosoh Endocrine Testing Introduction
10.19.4 Tosoh Revenue in Endocrine Testing Business (2015-2020)
10.19.5 Tosoh Recent Development
13.20 Wako
10.20.1 Wako Company Details
10.20.2 Wako Business Overview
10.20.3 Wako Endocrine Testing Introduction
10.20.4 Wako Revenue in Endocrine Testing Business (2015-2020)
10.20.5 Wako Recent Development
13.21 Wallac/PE
10.21.1 Wallac/PE Company Details
10.21.2 Wallac/PE Business Overview
10.21.3 Wallac/PE Endocrine Testing Introduction
10.21.4 Wallac/PE Revenue in Endocrine Testing Business (2015-2020)
10.21.5 Wallac/PE Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Endocrine Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Endocrine Testing Revenue
Table 3. Ranking of Global Top Endocrine Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Endocrine Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Tandem Mass Spectrometry
Table 6. Key Players of Immunoassay
Table 7. Global Endocrine Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Endocrine Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Endocrine Testing Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Endocrine Testing Market Share by Regions (2015-2020)
Table 11. Global Endocrine Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Endocrine Testing Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Endocrine Testing Market Growth Strategy
Table 17. Main Points Interviewed from Key Endocrine Testing Players
Table 18. Global Endocrine Testing Revenue by Players (2015-2020) (Million US$)
Table 19. Global Endocrine Testing Market Share by Players (2015-2020)
Table 20. Global Top Endocrine Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endocrine Testing as of 2019)
Table 21. Global Endocrine Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Endocrine Testing Product Solution and Service
Table 24. Date of Enter into Endocrine Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Endocrine Testing Market Size by Type (2015-2020) (Million US$)
Table 27. Global Endocrine Testing Market Size Share by Type (2015-2020)
Table 28. Global Endocrine Testing Revenue Market Share by Type (2021-2026)
Table 29. Global Endocrine Testing Market Size Share by Application (2015-2020)
Table 30. Global Endocrine Testing Market Size by Application (2015-2020) (Million US$)
Table 31. Global Endocrine Testing Market Size Share by Application (2021-2026)
Table 32. North America Key Players Endocrine Testing Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Endocrine Testing Market Share (2019-2020)
Table 34. North America Endocrine Testing Market Size by Type (2015-2020) (Million US$)
Table 35. North America Endocrine Testing Market Share by Type (2015-2020)
Table 36. North America Endocrine Testing Market Size by Application (2015-2020) (Million US$)
Table 37. North America Endocrine Testing Market Share by Application (2015-2020)
Table 38. Europe Key Players Endocrine Testing Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Endocrine Testing Market Share (2019-2020)
Table 40. Europe Endocrine Testing Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Endocrine Testing Market Share by Type (2015-2020)
Table 42. Europe Endocrine Testing Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Endocrine Testing Market Share by Application (2015-2020)
Table 44. China Key Players Endocrine Testing Revenue (2019-2020) (Million US$)
Table 45. China Key Players Endocrine Testing Market Share (2019-2020)
Table 46. China Endocrine Testing Market Size by Type (2015-2020) (Million US$)
Table 47. China Endocrine Testing Market Share by Type (2015-2020)
Table 48. China Endocrine Testing Market Size by Application (2015-2020) (Million US$)
Table 49. China Endocrine Testing Market Share by Application (2015-2020)
Table 50. Japan Key Players Endocrine Testing Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Endocrine Testing Market Share (2019-2020)
Table 52. Japan Endocrine Testing Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Endocrine Testing Market Share by Type (2015-2020)
Table 54. Japan Endocrine Testing Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Endocrine Testing Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Endocrine Testing Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Endocrine Testing Market Share (2019-2020)
Table 58. Southeast Asia Endocrine Testing Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Endocrine Testing Market Share by Type (2015-2020)
Table 60. Southeast Asia Endocrine Testing Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Endocrine Testing Market Share by Application (2015-2020)
Table 62. India Key Players Endocrine Testing Revenue (2019-2020) (Million US$)
Table 63. India Key Players Endocrine Testing Market Share (2019-2020)
Table 64. India Endocrine Testing Market Size by Type (2015-2020) (Million US$)
Table 65. India Endocrine Testing Market Share by Type (2015-2020)
Table 66. India Endocrine Testing Market Size by Application (2015-2020) (Million US$)
Table 67. India Endocrine Testing Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Endocrine Testing Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Endocrine Testing Market Share (2019-2020)
Table 70. Central & South America Endocrine Testing Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Endocrine Testing Market Share by Type (2015-2020)
Table 72. Central & South America Endocrine Testing Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Endocrine Testing Market Share by Application (2015-2020)
Table 74. Abbott Laboratories Company Details
Table 75. Abbott Laboratories Business Overview
Table 76. Abbott Laboratories Product
Table 77. Abbott Laboratories Revenue in Endocrine Testing Business (2015-2020) (Million US$)
Table 78. Abbott Laboratories Recent Development
Table 79. AdnaGen Company Details
Table 80. AdnaGen Business Overview
Table 81. AdnaGen Product
Table 82. AdnaGen Revenue in Endocrine Testing Business (2015-2020) (Million US$)
Table 83. AdnaGen Recent Development
Table 84. Beckman Coulter/Danaher Company Details
Table 85. Beckman Coulter/Danaher Business Overview
Table 86. Beckman Coulter/Danaher Product
Table 87. Beckman Coulter/Danaher Revenue in Endocrine Testing Business (2015-2020) (Million US$)
Table 88. Beckman Coulter/Danaher Recent Development
Table 89. Biomedical Diagnostics Company Details
Table 90. Biomedical Diagnostics Business Overview
Table 91. Biomedical Diagnostics Product
Table 92. Biomedical Diagnostics Revenue in Endocrine Testing Business (2015-2020) (Million US$)
Table 93. Biomedical Diagnostics Recent Development
Table 94. BioMerieux Company Details
Table 95. BioMerieux Business Overview
Table 96. BioMerieux Product
Table 97. BioMerieux Revenue in Endocrine Testing Business (2015-2020) (Million US$)
Table 98. BioMerieux Recent Development
Table 99. Bio-Rad Company Details
Table 100. Bio-Rad Business Overview
Table 101. Bio-Rad Product
Table 102. Bio-Rad Revenue in Endocrine Testing Business (2015-2020) (Million US$)
Table 103. Bio-Rad Recent Development
Table 104. Dako Company Details
Table 105. Dako Business Overview
Table 106. Dako Product
Table 107. Dako Revenue in Endocrine Testing Business (2015-2020) (Million US$)
Table 108. Dako Recent Development
Table 109. DiaSorin Business Overview
Table 110. DiaSorin Product
Table 111. DiaSorin Company Details
Table 112. DiaSorin Revenue in Endocrine Testing Business (2015-2020) (Million US$)
Table 113. DiaSorin Recent Development
Table 114. Eiken Company Details
Table 115. Eiken Business Overview
Table 116. Eiken Product
Table 117. Eiken Revenue in Endocrine Testing Business (2015-2020) (Million US$)
Table 118. Eiken Recent Development
Table 119. Fujirebio Company Details
Table 120. Fujirebio Business Overview
Table 121. Fujirebio Product
Table 122. Fujirebio Revenue in Endocrine Testing Business (2015-2020) (Million US$)
Table 123. Fujirebio Recent Development
Table 124. Instrumentation Laboratory Company Details
Table 125. Instrumentation Laboratory Business Overview
Table 126. Instrumentation Laboratory Product
Table 127. Instrumentation Laboratory Revenue in Endocrine Testing Business (2015-2020) (Million US$)
Table 128. Instrumentation Laboratory Recent Development
Table 129. Kyowa Medex Company Details
Table 130. Kyowa Medex Business Overview
Table 131. Kyowa Medex Product
Table 132. Kyowa Medex Revenue in Endocrine Testing Business (2015-2020) (Million US$)
Table 133. Kyowa Medex Recent Development
Table 134. Matritech Company Details
Table 135. Matritech Business Overview
Table 136. Matritech Product
Table 137. Matritech Revenue in Endocrine Testing Business (2015-2020) (Million US$)
Table 138. Matritech Recent Development
Table 139. Ortho-Clinical Diagnostics Company Details
Table 140. Ortho-Clinical Diagnostics Business Overview
Table 141. Ortho-Clinical Diagnostics Product
Table 142. Ortho-Clinical Diagnostics Revenue in Endocrine Testing Business (2015-2020) (Million US$)
Table 143. Ortho-Clinical Diagnostics Recent Development
Table 144. Roche Company Details
Table 145. Roche Business Overview
Table 146. Roche Product
Table 147. Roche Revenue in Endocrine Testing Business (2015-2020) (Million US$)
Table 148. Roche Recent Development
Table 149. Siemens Company Details
Table 150. Siemens Business Overview
Table 151. Siemens Product
Table 152. Siemens Revenue in Endocrine Testing Business (2015-2020) (Million US$)
Table 153. Siemens Recent Development
Table 154. Sysmex Company Details
Table 155. Sysmex Business Overview
Table 156. Sysmex Product
Table 157. Sysmex Revenue in Endocrine Testing Business (2015-2020) (Million US$)
Table 158. Sysmex Recent Development
Table 159. Thermo Fisher Company Details
Table 160. Thermo Fisher Business Overview
Table 161. Thermo Fisher Product
Table 162. Thermo Fisher Revenue in Endocrine Testing Business (2015-2020) (Million US$)
Table 163. Thermo Fisher Recent Development
Table 164. Tosoh Company Details
Table 165. Tosoh Business Overview
Table 166. Tosoh Product
Table 167. Tosoh Revenue in Endocrine Testing Business (2015-2020) (Million US$)
Table 168. Tosoh Recent Development
Table 169. Wako Company Details
Table 170. Wako Business Overview
Table 171. Wako Product
Table 172. Wako Revenue in Endocrine Testing Business (2015-2020) (Million US$)
Table 173. Wako Recent Development
Table 174. Wallac/PE Company Details
Table 175. Wallac/PE Business Overview
Table 176. Wallac/PE Product
Table 177. Wallac/PE Revenue in Endocrine Testing Business (2015-2020) (Million US$)
Table 178. Wallac/PE Recent Development
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endocrine Testing Market Share by Type: 2020 VS 2026
Figure 2. Tandem Mass Spectrometry Features
Figure 3. Immunoassay Features
Figure 4. Global Endocrine Testing Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Commercial Laboratories Case Studies
Figure 7. Ambulatory Care Centres Case Studies
Figure 8. Other Setting Case Studies
Figure 9. Endocrine Testing Report Years Considered
Figure 10. Global Endocrine Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Endocrine Testing Market Share by Regions: 2020 VS 2026
Figure 12. Global Endocrine Testing Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Endocrine Testing Market Share by Players in 2019
Figure 15. Global Top Endocrine Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endocrine Testing as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Endocrine Testing Revenue in 2019
Figure 17. North America Endocrine Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Endocrine Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Endocrine Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Endocrine Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Endocrine Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Endocrine Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Endocrine Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs